VPIM
CSCI

Vanguard Personalized Indexing Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-148
Closed -$5K – 1241
2021
Q4 		$5K Buy
+148
New +$7.8K ﹤0.01% 1057

Other funds holding CSCI

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Personalized Indexing Management's CSCI Position: Q1 2022 in Review

Vanguard Personalized Indexing Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q1 2022, closing a stake of 148 shares — an estimated $5K sold.

Vanguard Personalized Indexing Management first reported a position in CSCI in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 23 funds tracked by Wall St. Rank hold CSCI as of Q1 2022.

  • Vanguard Personalized Indexing Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 148 COSCIENS Biopharma Inc. Common Stock shares in Q1 2022, an estimated $5K.
  • Vanguard Personalized Indexing Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's COSCIENS Biopharma Inc. Common Stock position peaked at $5K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q1 2022.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2022, filed 16 May 2022.